CON insider filing: 60,000 restricted shares granted; total 120,000

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. On 11/04/2025, an officer received 60,000 shares of common stock at a price of $0 under a restricted stock award. Following the grant, the officer beneficially owns 120,000 shares, held directly.

The award is described as restricted stock that will vest in equal annual installments over four years. The reporting person is identified as Executive Vice President, Chief Growth & Customer Officer. The transaction was coded as an acquisition of securities.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Conser Jonathan P.

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	60,000	$0.00	--

Holdings After Transaction: Common Stock — 120,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conser Jonathan P.

(Last) (First) (Middle)

C/O CONCENTRA GROUP HOLDINGS PARENT, INC

5080 SPECTRUM DRIVE, SUITE 1200W

(Street)

ADDISON TX 75001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentra Group Holdings Parent, Inc. [ CON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2025		A(1)		60,000	A	$0	120,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock which will vest in equal annual installments over four years.

Remarks:

Executive Vice President, Chief Growth & Customer Officer

	/s/ Timothy F. Ryan, Attorney-in-Fact	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Concentra (CON) disclose in this Form 4?

An officer was granted 60,000 shares of restricted common stock on 11/04/2025 at $0 price.

What is the vesting schedule for the CON restricted stock grant?

The restricted stock will vest in equal annual installments over four years.

How many CON shares does the officer own after the transaction?

The officer beneficially owns 120,000 shares following the reported transaction, held directly.

What role does the reporting person hold at Concentra (CON)?

The reporting person serves as Executive Vice President, Chief Growth & Customer Officer.

What was the transaction code and security type?

Transaction code A for an acquisition of common stock via a restricted stock grant.

Was there a purchase price for the granted shares?

The reported price was $0, consistent with a restricted stock grant.